Michael Deutsch, MD
Colon & Rectal Surgery · West Reading, PANPI 1356668602
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,000 of the $9,459 with a category attached, or 95.2%. Intuitive Surgical accounts for 98.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $6,334 and has fallen 98.7% since, to $83 in 2025.
Across 15 payments — averaging $630.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Biocomposites Inc$83
- Johnson & Johnson$21
Across 20 payments — averaging $2583.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$52K
What the payments were for
- Travel & lodging$460%
- Food & beverage$4134%
- Education$9,00095%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $9,355 |
| Biocomposites Inc | 1 | $83 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,000
How this compares
$9,459 in reported general payments places this provider in the 85th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 21 | $534 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $114 |
| Neomycin Sulfate | 23 | $74 |
| Metronidazole | 43 | $64 |
| Oxycodone Hcl | 20 | $46 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in West Reading
- Wayne DevosWest Reading$2K
- Bogdan ProtyniakWilkes-Barre$429K
- John MarksWynnewood$155K
- Joshua BleierPhiladelphia$86K
- Richard FortunatoPittsburgh$80K
- Najjia MahmoudPhiladelphia$63K
- James McCormickMonroeville$55K
- Juan PoggioPhiladelphia$49K
- Christopher BuzasDanville$25K
- David ZebleyAbington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.